CompletedNCT01186432
Preliminary Safety and Efficacy of the PDS-1.0 in Patients With Neovascular Age Related Macular Degeneration (AMD)
PHASE1 · 20 planned enrolment
- Countries listed
- 1
- Registry update
- March 5, 2015
immortal.lifeTrial registrations containing the exact intervention label PDS 1.0.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE1 · 20 planned enrolment
PHASE1 · 0 planned enrolment